| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A M Palmer, P T Francis, J S Benton, N R Sims, D M Mann, D Neary, J S Snowden, D M Bowe. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. Journal of neurochemistry. vol 48. issue 1. 1987-01-29. PMID:2432177. |
indices of presynaptic serotonergic nerve endings were assayed in neocortical biopsy samples from patients with histologically verified alzheimer's disease. |
1987-01-29 |
2023-08-11 |
Not clear |
| A M Palmer, P T Francis, J S Benton, N R Sims, D M Mann, D Neary, J S Snowden, D M Bowe. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. Journal of neurochemistry. vol 48. issue 1. 1987-01-29. PMID:2432177. |
values for serotonergic markers in alzheimer's disease samples did not show correlations with rating of the severity of dementia, indices of cholinergic innervation, or senile plaque and cortical pyramidal neurone loss. |
1987-01-29 |
2023-08-11 |
Not clear |
| D L Sparks, W R Markesbery, J T Slevi. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis. Annals of neurology. vol 19. issue 6. 1986-08-13. PMID:2425718. |
these data indicate a loss of both dopaminergic and serotonergic synapses in the nbm of patients with alzheimer's disease. |
1986-08-13 |
2023-08-11 |
Not clear |
| T Yamamoto, A Hiran. Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam. Acta neuropathologica. vol 67. issue 3-4. 1985-11-01. PMID:4050345. |
recently, morphometric analysis has shown that the nucleus raphe dorsalis, which is presumed to project diffuse serotonergic fibers to the telencephalon, is affected in alzheimer's disease. |
1985-11-01 |
2023-08-11 |
Not clear |
| E K Perry, R H Perry, J M Candy, A F Fairbairn, G Blessed, D J Dick, B E Tomlinso. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neuroscience letters. vol 51. issue 3. 1985-03-21. PMID:6521962. |
reductions in the numbers of binding sites for the serotonergic s2-receptor antagonist, ketanserin, are, as previously reported, evident in alzheimer's disease. |
1985-03-21 |
2023-08-12 |
Not clear |
| D M Bowen, S J Allen, J S Benton, M J Goodhardt, E A Haan, A M Palmer, N R Sims, C C Smith, J A Spillane, M M Esiri, D Neary, J S Snowdon, G K Wilcock, A N Daviso. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. Journal of neurochemistry. vol 41. issue 1. 1983-08-11. PMID:6306169. |
biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in alzheimer's disease. |
1983-08-11 |
2023-08-12 |
Not clear |